Factors Associated with COVID-19 Breakthrough Infection Among Vaccinated Patients with Rheumatic Diseases: A Cohort Study

{ 'indexed': { 'date-parts': [[2022, 10, 27]], 'date-time': '2022-10-27T04:59:46Z', 'timestamp': 1666846786484}, 'reference-count': 35, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2022, 10, 1]], 'date-time': '2022-10-01T00:00:00Z', 'timestamp': 1664582400000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2022, 10, 1]], 'date-time': '2022-10-01T00:00:00Z', 'timestamp': 1664582400000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-017'}, { 'start': { 'date-parts': [[2022, 10, 1]], 'date-time': '2022-10-01T00:00:00Z', 'timestamp': 1664582400000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-037'}, { 'start': { 'date-parts': [[2022, 10, 1]], 'date-time': '2022-10-01T00:00:00Z', 'timestamp': 1664582400000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-012'}, { 'start': { 'date-parts': [[2022, 10, 1]], 'date-time': '2022-10-01T00:00:00Z', 'timestamp': 1664582400000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-029'}, { 'start': { 'date-parts': [[2022, 10, 1]], 'date-time': '2022-10-01T00:00:00Z', 'timestamp': 1664582400000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-004'}], 'content-domain': { 'domain': [ 'clinicalkey.fr', 'clinicalkey.jp', 'clinicalkey.com.au', 'clinicalkey.es', 'clinicalkey.com', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2022, 10]]}, 'DOI': '10.1016/j.semarthrit.2022.152108', 'type': 'journal-article', 'created': { 'date-parts': [[2022, 10, 26]], 'date-time': '2022-10-26T23:46:53Z', 'timestamp': 1666828013000}, 'page': '152108', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Factors Associated with COVID-19 Breakthrough Infection Among Vaccinated Patients with Rheumatic ' 'Diseases: A Cohort Study', 'prefix': '10.1016', 'author': [ {'given': 'Naomi J.', 'family': 'Patel', 'sequence': 'first', 'affiliation': []}, {'given': 'Xiaosong', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xiaoqing', 'family': 'Fu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yumeko', 'family': 'Kawano', 'sequence': 'additional', 'affiliation': []}, {'given': 'Claire', 'family': 'Cook', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kathleen M.M.', 'family': 'Vanni', 'sequence': 'additional', 'affiliation': []}, {'given': 'Grace', 'family': 'Qian', 'sequence': 'additional', 'affiliation': []}, {'given': 'Emily', 'family': 'Banasiak', 'sequence': 'additional', 'affiliation': []}, {'given': 'Emily', 'family': 'Kowalski', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yuqing', 'family': 'Zhang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jeffrey A.', 'family': 'Sparks', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-4708-7038', 'authenticated-orcid': False, 'given': 'Zachary S.', 'family': 'Wallace', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.semarthrit.2022.152108_bib0001', 'doi-asserted-by': 'crossref', 'first-page': 'e430', 'DOI': '10.1016/S2665-9913(22)00096-0', 'article-title': 'Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes ' 'among individuals with immune-mediated inflammatory diseases tested ' 'between March 1 and Nov 22, 2021, in Ontario, Canada: a ' 'population-based analysis', 'volume': '4', 'author': 'Widdifield', 'year': '2022', 'journal-title': 'Lancet Rheumatol'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0002', 'doi-asserted-by': 'crossref', 'first-page': '289', 'DOI': '10.1136/annrheumdis-2021-221326', 'article-title': 'Clinical characteristics and outcomes of COVID-19 breakthrough ' 'infections among vaccinated patients with systemic autoimmune rheumatic ' 'diseases', 'volume': '81', 'author': 'Cook', 'year': '2022', 'journal-title': 'Ann Rheum Dis'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0003', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.coph.2022.102243', 'article-title': 'Immunogenicity, breakthrough infection, and underlying disease flare ' 'after SARS-CoV-2 vaccination among individuals with systemic autoimmune ' 'rheumatic diseases', 'volume': '65', 'author': 'Paik', 'year': '2022', 'journal-title': 'Curr Opin Pharmacol'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0004', 'doi-asserted-by': 'crossref', 'DOI': '10.1136/rmdopen-2021-002187', 'article-title': 'SARS-CoV-2 Breakthrough Infections Among Vaccinated Individuals with ' 'Rheumatic Disease: Results From the COVID-19 Global Rheumatology ' 'Alliance Provider Registry', 'volume': '8', 'author': 'Liew', 'year': '2022', 'journal-title': 'RMD Open'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0005', 'doi-asserted-by': 'crossref', 'first-page': '1652', 'DOI': '10.1016/j.cmi.2021.06.036', 'article-title': 'BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully ' 'vaccinated hospitalized COVID-19 patients in Israel', 'volume': '27', 'author': 'Brosh-Nissimov', 'year': '2021', 'journal-title': 'Clin Microbiol Infect'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0006', 'doi-asserted-by': 'crossref', 'first-page': '1248', 'DOI': '10.1080/13696998.2021.2002063', 'article-title': 'Evaluation of COVID-19 vaccine breakthrough infections among ' 'immunocompromised patients fully vaccinated with BNT162b2', 'volume': '24', 'author': 'Di Fusco', 'year': '2021', 'journal-title': 'J Med Econ'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0007', 'doi-asserted-by': 'crossref', 'first-page': '1156', 'DOI': '10.1136/annrheumdis-2020-217888', 'article-title': 'Clinical characteristics and outcomes of patients with coronavirus ' 'disease 2019 (COVID-19) and rheumatic disease: a comparative cohort ' "study from a US 'hot spot'", 'volume': '79', 'author': "D'Silva", 'year': '2020', 'journal-title': 'Ann Rheum Dis'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0008', 'article-title': 'Coronavirus disease 2019 outcomes among patients with rheumatic ' 'diseases 6 months into the pandemic', 'author': 'Serling-Boyd', 'year': '2020', 'journal-title': 'Ann Rheum Dis'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0009', 'doi-asserted-by': 'crossref', 'unstructured': 'Deepak P, Kim W, Paley MA, et al. Glucocorticoids and B Cell Depleting ' 'Agents Substantially Impair Immunogenicity of mRNA Vaccines to ' 'SARS-CoV-2. medRxiv2021:1-41.', 'DOI': '10.1101/2021.04.05.21254656'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0010', 'doi-asserted-by': 'crossref', 'first-page': '1255', 'DOI': '10.1136/annrheumdis-2021-221244', 'article-title': 'Impact of disease-modifying antirheumatic drugs on vaccine ' 'immunogenicity in patients with inflammatory rheumatic and ' 'musculoskeletal diseases', 'volume': '80', 'author': 'Friedman', 'year': '2021', 'journal-title': 'Ann Rheum Dis'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0011', 'doi-asserted-by': 'crossref', 'first-page': '1339', 'DOI': '10.1136/annrheumdis-2021-220597', 'article-title': 'Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine ' 'in immune-mediated inflammatory disease', 'volume': '80', 'author': 'Haberman', 'year': '2021', 'journal-title': 'Ann Rheum Dis'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0012', 'doi-asserted-by': 'crossref', 'first-page': '33', 'DOI': '10.1002/art.41914', 'article-title': 'Humoral and Cellular Immune Responses to SARS-CoV-2 Infection and ' 'Vaccination in Autoimmune Disease Patients With B Cell Depletion', 'volume': '74', 'author': 'Simon', 'year': '2022', 'journal-title': 'Arthritis Rheumatol'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0013', 'article-title': 'Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in ' 'adult patients with autoimmune inflammatory rheumatic diseases and in ' 'the general population: a multicentre study', 'author': 'Furer', 'year': '2021', 'journal-title': 'Ann Rheum Dis'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0014', 'doi-asserted-by': 'crossref', 'first-page': '145', 'DOI': '10.1136/annrheumdis-2021-221217', 'article-title': 'SARS-CoV-2 infection after vaccination in patients with inflammatory ' 'rheumatic and musculoskeletal diseases', 'volume': '81', 'author': 'Lawson-Tovey', 'year': '2022', 'journal-title': 'Ann Rheum Dis'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0015', 'doi-asserted-by': 'crossref', 'article-title': 'COVID-19 infection and hospitalisation risk according to vaccination ' 'status and DMARD treatment in patients with rheumatoid arthritis', 'author': 'Cordtz', 'year': '2022', 'journal-title': 'Rheumatology (Oxford)', 'DOI': '10.1093/rheumatology/keac241'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0016', 'doi-asserted-by': 'crossref', 'first-page': 'e417', 'DOI': '10.1016/S2665-9913(22)00102-3', 'article-title': 'Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant ' 'in vaccinated patients with immune-mediated inflammatory diseases using ' 'immunosuppressants: a substudy of two prospective cohort studies', 'volume': '4', 'author': 'Boekel', 'year': '2022', 'journal-title': 'Lancet Rheumatol'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0017', 'doi-asserted-by': 'crossref', 'first-page': '153', 'DOI': '10.1001/jamainternmed.2021.7024', 'article-title': 'Association Between Immune Dysfunction and COVID-19 Breakthrough ' 'Infection After SARS-CoV-2 Vaccination in the US', 'volume': '182', 'author': 'Sun', 'year': '2022', 'journal-title': 'JAMA Intern Med'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0018', 'unstructured': 'COVID-19 Vaccines for People who are Moderately or Severely ' 'Immunocompromised. (Accessed July 5, 2022, at ' 'https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html#:∼:text=For%20people%20who%20are%20immunocompromised,may%20have%20decreased%20over%20time.)'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0019', 'unstructured': 'Massachusetts Immunization Information System (MIIS). (Accessed July 5, ' '2022, at ' 'https://www.mass.gov/massachusetts-immunization-information-system-miis.)'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0020', 'unstructured': 'Latest Data on COVID-19 Vaccinations by Race/Ethnicity. (Accessed July ' '5, 2022, at ' 'https://www.kff.org/coronavirus-covid-19/issue-brief/latest-data-on-covid-19-vaccinations-by-race-ethnicity/.)'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0021', 'doi-asserted-by': 'crossref', 'first-page': 'R32', 'DOI': '10.1186/ar3260', 'article-title': 'Validation of rheumatoid arthritis diagnoses in health care utilization ' 'data', 'volume': '13', 'author': 'Kim', 'year': '2011', 'journal-title': 'Arthritis Res Ther'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0022', 'first-page': '1044', 'article-title': 'Calculating the Benefits of a Research Patient Data Repository', 'author': 'Nalichowski', 'year': '2006', 'journal-title': 'AMIA Annu Symp Proc'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0023', 'doi-asserted-by': 'crossref', 'first-page': '373', 'DOI': '10.1016/0021-9681(87)90171-8', 'article-title': 'A new method of classifying prognostic comorbidity in longitudinal ' 'studies: Development and validation', 'volume': '40', 'author': 'Charlson', 'year': '1987', 'journal-title': 'J Chron Dis'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0024', 'unstructured': 'Tracking the Omicron variant in Massachusetts. (Accessed July 5, 2022, ' 'at ' 'https://www.broadinstitute.org/news/tracking-omicron-variant-massachusetts.)'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0025', 'year': '2022', 'journal-title': 'Centers for Disease Control and Prevention'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0026', 'doi-asserted-by': 'crossref', 'DOI': '10.1136/rmdopen-2022-002279', 'article-title': 'Clinical outcomes of breakthrough COVID-19 after booster vaccination in ' 'patients with systemic rheumatic diseases', 'volume': '8', 'author': 'Fragoulis', 'year': '2022', 'journal-title': 'RMD Open'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0027', 'doi-asserted-by': 'crossref', 'first-page': '1345', 'DOI': '10.1136/annrheumdis-2021-220781', 'article-title': 'SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote ' 'humoral immune responses in the presence of T-cell-mediated immunity', 'volume': '80', 'author': 'Mrak', 'year': '2021', 'journal-title': 'Ann Rheum Dis'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0028', 'doi-asserted-by': 'crossref', 'first-page': '1990', 'DOI': '10.1038/s41591-021-01507-2', 'article-title': 'Cellular and humoral immune responses following SARS-CoV-2 mRNA ' 'vaccination in patients with multiple sclerosis on anti-CD20 therapy', 'volume': '27', 'author': 'Apostolidis', 'year': '2021', 'journal-title': 'Nat Med'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0029', 'doi-asserted-by': 'crossref', 'article-title': 'COVID-19 vaccine effectiveness against omicron (B.1.1.529) variant ' 'infection and hospitalisation in patients taking immunosuppressive ' 'medications: a retrospective cohort study', 'author': 'Risk', 'year': '2022', 'journal-title': 'The Lancet Rheumatology', 'DOI': '10.1016/S2665-9913(22)00216-8'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0030', 'article-title': 'Associations of baseline use of biologic or targeted synthetic DMARDs ' 'with COVID-19 severity in rheumatoid arthritis: Results from the ' 'COVID-19 Global Rheumatology Alliance physician registry', 'author': 'Sparks', 'year': '2021', 'journal-title': 'Ann Rheum Dis'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0031', 'doi-asserted-by': 'crossref', 'first-page': 'e419', 'DOI': '10.1016/S2665-9913(21)00059-X', 'article-title': 'COVID-19 outcomes in patients with inflammatory rheumatic and ' 'musculoskeletal diseases treated with rituximab: a cohort study', 'volume': '3', 'author': 'Avouac', 'year': '2021', 'journal-title': 'Lancet Rheumatol'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0032', 'doi-asserted-by': 'crossref', 'article-title': 'Postvaccination antibody titres predict protection against COVID-19 in ' 'patients with autoimmune diseases: survival analysis in a prospective ' 'cohort', 'author': 'Ahmed', 'year': '2022', 'journal-title': 'Ann Rheum Dis', 'DOI': '10.1136/annrheumdis-2021-221922'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0033', 'doi-asserted-by': 'crossref', 'first-page': '191', 'DOI': '10.1038/s41584-022-00755-x', 'article-title': 'COVID-19 in people with rheumatic diseases: risks, outcomes, treatment ' 'considerations', 'volume': '18', 'author': 'Grainger', 'year': '2022', 'journal-title': 'Nat Rev Rheumatol'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0034', 'doi-asserted-by': 'crossref', 'first-page': '105', 'DOI': '10.1056/NEJMoa2115463', 'article-title': 'Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. ' 'Veterans', 'volume': '386', 'author': 'Dickerman', 'year': '2022', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.semarthrit.2022.152108_bib0035', 'doi-asserted-by': 'crossref', 'first-page': '1700', 'DOI': '10.15585/mmwr.mm7049a2', 'article-title': 'Comparative Effectiveness and Antibody Responses to Moderna and ' 'Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five ' 'Veterans Affairs Medical Centers, United States, February 1–September ' '30, 2021', 'volume': '70', 'author': 'Bajema', 'year': '2021', 'journal-title': 'MMWR Morb Mortal Wkly Rep'}], 'container-title': 'Seminars in Arthritis and Rheumatism', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0049017222001597?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0049017222001597?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2022, 10, 26]], 'date-time': '2022-10-26T23:47:13Z', 'timestamp': 1666828033000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0049017222001597'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 10]]}, 'references-count': 35, 'alternative-id': ['S0049017222001597'], 'URL': 'http://dx.doi.org/10.1016/j.semarthrit.2022.152108', 'relation': {}, 'ISSN': ['0049-0172'], 'subject': ['Anesthesiology and Pain Medicine', 'Rheumatology'], 'container-title-short': 'Seminars in Arthritis and Rheumatism', 'published': {'date-parts': [[2022, 10]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Factors Associated with COVID-19 Breakthrough Infection Among Vaccinated ' 'Patients with Rheumatic Diseases: A Cohort Study', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'Seminars in Arthritis and Rheumatism', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.semarthrit.2022.152108', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2022 Elsevier Inc. All rights reserved.', 'name': 'copyright', 'label': 'Copyright'}], 'article-number': '152108'}